title: Vaccines, thimerosal, and neurodevelopmental outcomes.
authors.affiliation: Clinical and Scientific Affairs Council, AAPA, USA.
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Herman
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Gerbert
authors.forename: Lyle W
authors.initials: LW
authors.lastname: Larson
authors.forename: Marie-Michèle
authors.initials: MM
authors.lastname: Léger
authors.forename: Robert
authors.initials: R
authors.lastname: McNellis
authors.forename: Daniel L
authors.initials: DL
authors.lastname: O'Donoghue
authors.forename: Cynthia
authors.initials: C
authors.lastname: Ulshafer
authors.forename: Eileen M
authors.initials: EM
authors.lastname: Van Dyke
mesh_terms: D002648:Child; D002658:Developmental Disabilities / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects* / Q000032:analysis; D013849:Thimerosal / Q000009:adverse effects* / Q000032:analysis; D014612:Vaccines / Q000737:chemistry*
chemical_list: D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal